E. Batlle, H. Clevers, Cancer stem cells revisited. Nat. Med. 23(10), 1124–1134 (2017). https://doi.org/10.1038/nm.4409
D. Hanahan, Hallmarks of Cancer: New dimensions. Cancer Discov. 12(1), 31–46 (2022). https://doi.org/10.1158/2159-8290.CD-21-1059
Z.J. Lei, J. Wang, H.L. Xiao, Y. Guo, T. Wang, Q. Li, L. Liu, X. Luo, L.L. Fan, L. Lin, C.Y. Mao, S.N. Wang, Y.L. Wei, C.H. Lan, J. Jiang, X.J. Yang, P.D. Liu, D.F. Chen, B. Wang, Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5(+) liver cancer initiating cells by suppressing negative regulators of β-catenin signaling. Oncogene 34(24), 3188–3198 (2015). https://doi.org/10.1038/onc.2015.129
Z. Wang, B. Wang, Y. Shi, C. Xu, H.L. Xiao, L.N. Ma, S.L. Xu, L. Yang, Q.L. Wang, W.Q. Dang, W. Cui, S.C. Yu, Y.F. Ping, Y.H. Cui, H.F. Kung, C. Qian, X. Zhang, X.W. Bian, Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2. Oncogene 34(11), 1407–1419 (2015). https://doi.org/10.1038/onc.2014.75
L. Deng, T. Meng, L. Chen, W. Wei, P. Wang, The role of ubiquitination in tumorigenesis and targeted drug discovery. Signal 5(1), 11 (2020). https://doi.org/10.1038/s41392-020-0107-0
D. Komander, M. Rape, The ubiquitin code. Annu. Rev. Biochem. 81, 203–229 (2012). https://doi.org/10.1146/annurev-biochem-060310-170328
T.E.T. Mevissen, D. Komander, Mechanisms of Deubiquitinase specificity and regulation. Annu. Rev. Biochem. 86, 159–192 (2017). https://doi.org/10.1146/annurev-biochem-061516-044916
T. Wang, H. Wu, S. Liu, Z. Lei, Z. Qin, L. Wen, K. Liu, X. Wang, Y. Guo, Q. Liu, L. Liu, J. Wang, L. Lin, C. Mao, X. Zhu, H. Xiao, X. Bian, D. Chen, C. Xu, B. Wang, SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance. Cancer Lett. 430, 11–24 (2018). https://doi.org/10.1016/j.canlet.2018.05.003
T. Wang, Z.Y. Qin, L.Z. Wen, Y. Guo, Q. Liu, Z.J. Lei, W. Pan, K.J. Liu, X.W. Wang, S.J. Lai, W.J. Sun, Y.L. Wei, L. Liu, L. Guo, Y.Q. Chen, J. Wang, H.L. Xiao, X.W. Bian, D.F. Chen, B. Wang, Epigenetic restriction of hippo signaling by MORC2 underlies stemness of hepatocellular carcinoma cells. Cell Death Differ. 25(12), 2086–2100 (2018). https://doi.org/10.1038/s41418-018-0095-6
L. Yang, P. Shi, G. Zhao, J. Xu, W. Peng, J. Zhang, G. Zhang, X. Wang, Z. Dong, F. Chen, H. Cui, Targeting cancer stem cell pathways for cancer therapy. Sig. Transduct. Target. Ther. 5(1), 8 (2020). https://doi.org/10.1038/s41392-020-0110-5
J.A. Clara, C. Monge, Y. Yang, N. Takebe, Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update. Nat. Rev. Clin. Oncol. 17(4), 204–232 (2020). https://doi.org/10.1038/s41571-019-0293-2
B. Wang, Z. Jie, D. Joo, A. Ordureau, P. Liu, W. Gan, J. Guo, J. Zhang, B.J. North, X. Dai, X. Cheng, X. Bian, L. Zhang, J.W. Harper, S.C. Sun, W. Wei, TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling. Nature 545(7654), 365–369 (2017). https://doi.org/10.1038/nature22344
A. Strikoudis, M. Guillamot, I. Aifantis, Regulation of stem cell function by protein ubiquitylation. EMBO Rep. 15(4), 365–382 (2014). https://doi.org/10.1002/embr.201338373
N. Cai, M. Li, J. Qu, G.H. Liu, J.C. Izpisua Belmonte, Post-translational modulation of pluripotency. J. Mol. Cell Biol. 4(4), 262–265 (2012). https://doi.org/10.1093/jmcb/mjs031
Y. Kong, Z. Wang, M. Huang, Z. Zhou, Y. Li, H. Miao, X. Wan, J. Huang, X. Mao, C. Chen, CUL7 promotes cancer cell survival through promoting Caspase-8 ubiquitination. Int. J. Cancer 145(5), 1371–1381 (2019). https://doi.org/10.1002/ijc.32239
L. Song, Z.Q. Luo, Post-translational regulation of ubiquitin signaling. J. Cell Biol. 218(6), 1776–1786 (2019). https://doi.org/10.1083/jcb.201902074
S. Haq, B. Suresh, S. Ramakrishna, Deubiquitylating enzymes as cancer stem cell therapeutics. Biochimica et biophysica acta Rev. Cancer 1869(1), 1–10 (2018). https://doi.org/10.1016/j.bbcan.2017.10.004
S.A. Abdul Rehman, Y.A. Kristariyanto, S.Y. Choi, P.J. Nkosi, S. Weidlich, K. Labib, K. Hofmann, Y. Kulathu, MINDY-1 is a member of an evolutionarily conserved and structurally distinct new family of deubiquitinating enzymes. Mol. Cell 63(1), 146–155 (2016). https://doi.org/10.1016/j.molcel.2016.05.009
M.A. Basar, D.B. Beck, A. Werner, Deubiquitylases in developmental ubiquitin signaling and congenital diseases. Cell Death Differ. 28(2), 538–556 (2021). https://doi.org/10.1038/s41418-020-00697-5
F.E. Morreale, H. Walden, Types of ubiquitin ligases. Cell 165(1), 248–248.e1 (2016). https://doi.org/10.1016/j.cell.2016.03.003
N. Zheng, N. Shabek, Ubiquitin ligases: Structure, function, and regulation. Annu. Rev. Biochem. 86, 129–157 (2017). https://doi.org/10.1146/annurev-biochem-060815-014922
D. Rotin, S. Kumar, Physiological functions of the HECT family of ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 10(6), 398–409 (2009). https://doi.org/10.1038/nrm2690
S. Singh, J. Ng, J. Sivaraman, Exploring the “Other” subfamily of HECT E3-ligases for therapeutic intervention. Pharmacol. Ther. 224, (2021). https://doi.org/10.1016/j.pharmthera.2021.107809
M.Y. Ryu, S.K. Cho, Y. Hong, J. Kim, J.H. Kim, G.M. Kim, Y.J. Chen, E. Knoch, B.L. Møller, W.T. Kim, M.F. Lyngkjær, S.W. Yang, Classification of barley U-box E3 ligases and their expression patterns in response to drought and pathogen stresses. BMC Genomics 20(1), 326 (2019). https://doi.org/10.1186/s12864-019-5696-z
K.K. Dove, R.E. Klevit, RING-between-RING E3 ligases: Emerging themes amid the variations. J. Mol. Biol. 429(22), 3363–3375 (2017). https://doi.org/10.1016/j.jmb.2017.08.008
P. Wang, X. Dai, W. Jiang, Y. Li, W. Wei, RBR E3 ubiquitin ligases in tumorigenesis. Semin. Cancer Biol. 67(Pt 2), 131–144 (2020). https://doi.org/10.1016/j.semcancer.2020.05.002
J. Low, W. Blosser, M. Dowless, L. Ricci-Vitiani, R. Pallini, R. de Maria, L. Stancato, Knockdown of ubiquitin ligases in glioblastoma cancer stem cells leads to cell death and differentiation. J. Biomol. Screen. 17(2), 152–162 (2012). https://doi.org/10.1177/1087057111422565
M. Quiroga, A. Rodríguez-Alonso, G. Alfonsín, J.J.E. Rodríguez, S.M. Breijo, V. Chantada, A. Figueroa, Protein degradation by E3 ubiquitin ligases in Cancer stem cells. Cancers 14(4), 990 (2022). https://doi.org/10.3390/cancers14040990
D. Senft, J. Qi, Z.A. Ronai, Ubiquitin ligases in oncogenic transformation and cancer therapy. Nat. Rev. Cancer 18(2), 69–88 (2018). https://doi.org/10.1038/nrc.2017.105
S. Hume, C.P. Grou, P. Lascaux, V. D'Angiolella, A.J. Legrand, K. Ramadan, G.L. Dianov, The NUCKS1-SKP2-p21/p27 axis controls S phase entry. Nat. Commun. 12(1), 6959 (2021). https://doi.org/10.1038/s41467-021-27124-8
A. Nowosad, P. Jeannot, C. Callot, J. Creff, R.T. Perchey, C. Joffre, P. Codogno, S. Manenti, A. Besson, p27 controls Ragulator and mTOR activity in amino acid-deprived cells to regulate the autophagy-lysosomal pathway and coordinate cell cycle and cell growth. Nat. Cell Biol. 22(9), 1076–1090 (2020). https://doi.org/10.1038/s41556-020-0554-4
J. Deng, X. Bai, X. Feng, J. Ni, J. Beretov, P. Graham, Y. Li, Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression. BMC Cancer 19(1), 618 (2019). https://doi.org/10.1186/s12885-019-5824-9
C.H. Chan, C.F. Li, W.L. Yang, Y. Gao, S.W. Lee, Z. Feng, H.Y. Huang, K.K.C. Tsai, L.G. Flores, Y. Shao, J.D. Hazle, D. Yu, W. Wei, D. Sarbassov, M.C. Hung, K.I. Nakayama, H.K. Lin, The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, Herceptin sensitivity, and tumorigenesis. Cell 151(4), 913–914 (2012). https://doi.org/10.1016/j.cell.2012.10.025
W.L. Yang, J. Wang, C.H. Chan, S.W. Lee, A.D. Campos, B. Lamothe, L. Hur, B.C. Grabiner, X. Lin, B.G. Darnay, H.K. Lin, The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science (New York, N.Y.) 325(5944), 1134–1138 (2009). https://doi.org/10.1126/science.1175065
C.H. Chan, J.K. Morrow, C.F. Li, Y. Gao, G. Jin, A. Moten, L.J. Stagg, J.E. Ladbury, Z. Cai, D. Xu, C.J. Logothetis, M.C. Hung, S. Zhang, H.K. Lin, Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression. Cell 154(3), 556–568 (2013). https://doi.org/10.1016/j.cell.2013.06.048
C.H. Yeh, M. Bellon, C. Nicot, FBXW7: A critical tumor suppressor of human cancers. Mol. Cancer 17(1), 115 (2018). https://doi.org/10.1186/s12943-018-0857-2
L. Reavie, S.M. Buckley, E. Loizou, S. Takeishi, B. Aranda-Orgilles, D. Ndiaye-Lobry, O. Abdel-Wahab, S. Ibrahim, K.I. Nakayama, I. Aifantis, Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression. Cancer Cell 23(3), 362–375 (2013). https://doi.org/10.1016/j.ccr.2013.01.025
Y. Zhao, X. Xiong, Y. Sun, Cullin-RING ligase 5: Functional characterization and its role in human cancers. Semin. Cancer Biol. 67(Pt 2), 61–79 (2020). https://doi.org/10.1016/j.semcancer.2020.04.003
X. Hong, H.T. Nguyen, Q. Chen, R. Zhang, Z. Hagman, P.M. Voorhoeve, S.M. Cohen, Opposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnover. EMBO J. 33(21), 2447–2457 (2014). https://doi.org/10.15252/embj.201489385
B. Cui, L. Gong, M. Chen, Y. Zhang, H. Yuan, J. Qin, D. Gao, CUL5-SOCS6 complex regulates mTORC2 function by targeting Sin1 for degradation. Cell Discov. 5, 52 (2019). https://doi.org/10.1038/s41421-019-0118-6
留言 (0)